ScreenerHero
CRLCharles River Laboratories International, Inc.
NYSE · US · Healthcare · Diagnostics & Research · criver.com
231.43USD+0.32%Mkt Cap: 11.15B $P/E: —

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Mode…

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/B
Avg
1M Perf
Lower
TMO
Thermo Fisher Scientific Inc.
$192.35BUSDP/E 28.4
DHR
Danaher Corporation
$137.04BUSDP/E 37.5
LONN
Lonza Group AG
$45.79BUSDP/E 44.2
IDXX
IDEXX Laboratories, Inc.
$44.57BUSDP/E 41.5
NTRA
Natera, Inc.
$40.64BUSD
WAT
Waters Corporation
$37.20BUSDP/E 48.3
A
Agilent Technologies, Inc.
$36.91BUSDP/E 26.2
IQV
IQVIA Holdings Inc.
$34.38BUSDP/E 25.6
ILMN
Illumina, Inc.
$29.40BUSDP/E 35.4
MTD
Mettler-Toledo International, Inc.
$26.44BUSDP/E 30.8
DGX
Quest Diagnostics Incorporated
$23.63BUSDP/E 23.6
LH
Labcorp Holdings Inc.
$23.32BUSDP/E 25.2
GH
Guardant Health, Inc.
$22.39BUSD
MEDP
Medpace Holdings, Inc.
$16.14BUSDP/E 35.6
ERF
Eurofins Scientific SE
$12.97BUSDP/E 27.0
RVTY
Revvity, Inc.
$12.60BUSDP/E 54.3
BIM
bioMérieux S.A.
$9.03BUSDP/E 21.1
TWST
Twist Bioscience Corporation
$6.22BUSD
BLLN
BillionToOne, Inc.
$5.68BUSDP/E 228.5
RDNT
RadNet, Inc.
$5.42BUSD
SHC
Sotera Health Company
$5.09BUSDP/E 43.6
VCYT
Veracyte, Inc.
$4.63BUSDP/E 53.7
DIA
DiaSorin S.p.A.
$3.60BUSDP/E 25.5
ADPT
Adaptive Biotechnologies Corp.
$3.39BUSD
GRAL
GRAIL, Inc.
$2.96BUSD
WGS
GeneDx Holdings Corp.
$2.05BUSD
NEO
NeoGenomics, Inc.
$1.97BUSD
VIMIAN
Vimian Group AB (publ)
$1.52BUSDP/E 38.7
DIA
Diagnostyka S.A.
$1.55BUSDP/E 23.3
PSNL
Personalis, Inc.
$1.50BUSD
CDNA
CareDx, Inc.
$1.50BUSD
OPK
OPKO Health, Inc.
$1.13BUSD
CBAV
Clínica Baviera, S.A.
$1.01BUSDP/E 21.1
CSTL
Castle Biosciences, Inc.
$734.29MUSD
LBIRD
Lumibird SA
$623.59MUSDP/E 40.6
FLGT
Fulgent Genetics, Inc.
$607.49MUSD
MYGN
Myriad Genetics, Inc.
$569.52MUSD
VOX
Voxel S.A.
$297.91MUSDP/E 3.0
EDT
Spectral Medical Inc.
$290.61MUSD
BDSX
Biodesix, Inc.
$226.27MUSD
IMDX
Insight Molecular Diagnostics Inc.
$182.12MUSD
SLV
Selvita S.A.
$141.76MUSD
XGN
Exagen Inc.
$106.30MUSD
SCP
Scope Fluidics S.A.
$97.25MUSD
ALECR
Eurofins-Cerep SA
$94.30MUSDP/E 18.1
BIOPOR
BioPorto A/S
$79.32MUSD
PANG
Pangaea Oncology, S.A.
$58.94MUSD
PRPO
Precipio, Inc.
$45.15MUSD
NN6
NanoRepro AG
$29.61MUSD
ABDX
Abingdon Health Plc
$27.97MUSD
GDR
genedrive plc
$21.38MUSD
SENZA
SenzaGen AB
$17.72MUSD
IMMNOV
Immunovia AB (publ)
$12.73MUSD
VRCI
Verici Dx plc
$12.18MUSD
BMX
BioMaxima S.A.
$9.97MUSDP/E 62.6
ALPRE
Predilife S.A.
$9.04MUSD
XWEL
XWELL, Inc.
$9.20MUSD
NDRA
ENDRA Life Sciences Inc.
$6.08MUSD
PRM
Proteome Sciences plc
$5.34MUSD
OBD
Oxford BioDynamics Plc
$4.90MUSD
BIAF
bioAffinity Technologies, Inc.
$5.08MUSD
AVCR
Avricore Health Inc.
$5.06MUSD
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
ISPC
iSpecimen Inc.
$3.69MUSD
PROGEN
Prostatype Genomics AB (publ)
$3.29MUSD
TELO
Telo Genomics Corp.
$3.29MUSD
NOTV
Inotiv Inc
$2.79MUSD
PRPH
ProPhase Labs, Inc.
$1.01MUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$56.1KUSD
Indicators:|

Key Statistics

Company
Market Cap11.15B $
Enterprise Value13.84B $
Revenue (TTM)4.03B $
Gross Profit1.32B $
Net Income (TTM)-144.34M $
Revenue/Share81.96 USD
Last Price231.43 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees18.3K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS1598641074
Valuation
P/E (Trailing)—
P/E (Forward)18.43
PEG0.12
EV/EBITDA15.56
EV/Revenue3.44
P/S2.71
P/B3.71
EPS (TTM)-3.70
EPS (Forward)12.31
52W Range
144.2694% of range236.62
52W High236.62 USD
52W Low144.26 USD
Profitability
Gross Margin32.96%
Oper. Margin15.92%
EBITDA Margin22.09%
Profit Margin-3.59%
ROE-4.56%
ROA-2.02%
Growth
Revenue Growth1.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF737.65M $
CapEx (TTM)219.15M $
FCF Margin12.66%
FCF Yield4.58%
Net Debt2.87B $
Net Debt/EBITDA3.23
Balance Sheet
Debt/Equity0.81
Current Ratio1.36
Quick Ratio0.82
Book Value/Sh61.05 USD
Cash/Share3.983 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)215.33 USD
Upside (mean)-7.0%
Target Range135.00 USD – 265.00 USD
$135.00-7.0% to mean$265.00
# Analysts15
Ownership
Shares Out.48.17M
Float47.58M
Insiders0.64%
Institutions123.40%
Short Interest
Short Ratio4.1d
Short % Float8.66%
Short % Out.7.50%
Shares Short3.61M
Short (prev mo.)3.63M
Technical
SMA 50177.72 (+30.2%)
SMA 200179.33 (+29.1%)
Beta1.45
S&P 52W Chg20.05%
Avg Vol (30d)630.50K
Avg Vol (10d)985.95K
Technical Indicators
RSI (14)78.8
MACD14.4060
MACD Signal10.6257
MACD Hist.+3.7802
BB Upper238.79 USD
BB Middle200.12 USD
BB Lower161.45 USD
BB Width38.65%
ATR (14)8.197 USD
Vol Ratio (20d)0.72x